Is HLA-A*3101 screening cost-effective for preventing carbamazepine-induced severe toxidermia?
| Data(s) |
2014
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_62DC0CDAF100 http://my.unil.ch/serval/document/BIB_62DC0CDAF100.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_62DC0CDAF1004 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
Euopean and Swiss Congress of Internal Medicine |
| Tipo |
info:eu-repo/semantics/conferenceObject inproceedings |
